These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1581704)

  • 21. Prostaglandin E2 prevents ovariectomy-induced cancellous bone loss in rats.
    Ke HZ; Li M; Jee WS
    Bone Miner; 1992 Oct; 19(1):45-62. PubMed ID: 1422305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous PGE2 leads to net bone loss while intermittent PGE2 leads to net bone gain in lumbar vertebral bodies of adult female rats.
    Tian XY; Zhang Q; Zhao R; Setterberg RB; Zeng QQ; Iturria SJ; Ma YF; Jee WS
    Bone; 2008 May; 42(5):914-20. PubMed ID: 18316259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extra cancellous bone induced by combined prostaglandin E2 and risedronate administration is maintained after their withdrawal in older female rats.
    Jee WS; Lin BY; Ma YF; Ke HZ
    J Bone Miner Res; 1995 Jun; 10(6):963-70. PubMed ID: 7572321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure.
    Tang LY; Jee WS; Ke HZ; Kimmel DB
    J Bone Miner Res; 1992 Sep; 7(9):1093-104. PubMed ID: 1414502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats.
    Li M; Jee WS; Ke HZ; Tang LY; Ma YF; Liang XG; Setterberg RB
    J Bone Miner Res; 1995 Jan; 10(1):66-73. PubMed ID: 7747632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia.
    Ke HZ; Shen VW; Qi H; Crawford DT; Wu DD; Liang XG; Chidsey-Frink KL; Pirie CM; Simmons HA; Thompson DD
    Bone; 1998 Sep; 23(3):249-55. PubMed ID: 9737347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of prostaglandin E2 and risedronate administration on cancellous bone in older female rats.
    Lin BY; Jee WS; Ma YF; Ke HZ; Kimmel DB; Li XJ
    Bone; 1994; 15(5):489-96. PubMed ID: 7980959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lumbar vertebral cancellous bone is capable of responding to PGE2 treatment by stimulating both modeling and remodeling-dependent bone gain in aged male rats.
    Zhou H; Ma YF; Yao W; Cui L; Setterberg R; Liang CT; Jee WS
    Calcif Tissue Int; 2001 Mar; 68(3):179-84. PubMed ID: 11351502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancellous bone of aged rats maintains its capacity to respond vigorously to the anabolic effects of prostaglandin E2 by modeling-dependent bone gain.
    Cui L; Ma YF; Yao W; Zhou H; Setterberg RB; Liang TC; Jee WS
    J Bone Miner Metab; 2001; 19(1):29-37. PubMed ID: 11156470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E2 administered by subcutaneous pellets causes local inflammation and systemic bone loss: a model for inflammation-induced bone disease.
    Desimone DP; Greene VS; Hannon KS; Turner RT; Bell NH
    J Bone Miner Res; 1993 May; 8(5):625-34. PubMed ID: 8511990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parathyroid hormone and mechanical usage have a synergistic effect in rat tibial diaphyseal cortical bone.
    Ma Y; Jee WS; Yuan Z; Wei W; Chen H; Pun S; Liang H; Lin C
    J Bone Miner Res; 1999 Mar; 14(3):439-48. PubMed ID: 10027909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermittent treatment of prostaglandin E2 with risedronate is more anabolic than prostaglandin E2 alone in the proximal tibial metaphysis of ovariectomized rats.
    Chen HK; Jee WS; Ma YF; Pan Z; McOsker JE; Li XJ
    Bone; 1995 Oct; 17(4 Suppl):285S-289S. PubMed ID: 8579930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption.
    Varela A; Chouinard L; Lesage E; Smith SY; Hattersley G
    J Bone Miner Res; 2017 Jan; 32(1):24-33. PubMed ID: 27748532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats.
    Ke HZ; Crawford DT; Qi H; Simmons HA; Owen TA; Paralkar VM; Li M; Lu B; Grasser WA; Cameron KO; Lefker BA; DaSilva-Jardine P; Scott DO; Zhang Q; Tian XY; Jee WS; Brown TA; Thompson DD
    J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermittent treatments of prostaglandin E2 plus risedronate and prostaglandin E2 alone are equally anabolic on tibial shaft of ovariectomized rats.
    Pan Z; Jee WS; Ma YF; McOsker JE; Li XJ
    Bone; 1995 Oct; 17(4 Suppl):291S-296S. PubMed ID: 8579931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S-ketoprofen inhibits tenotomy-induced bone loss and dynamics in weanling rats.
    Zeng QQ; Jee WS; Ke HZ; Wechter WJ
    Bone Miner; 1993 Jun; 21(3):203-18. PubMed ID: 8400920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin E2 increases the skeletal response to mechanical loading.
    Tang LY; Cullen DM; Yee JA; Jee WS; Kimmel DB
    J Bone Miner Res; 1997 Feb; 12(2):276-82. PubMed ID: 9041061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of systemic prostaglandin E2 on bone mass in rat long bones and calvariae.
    Suponitzky I; Weinreb M
    J Endocrinol; 1998 Jan; 156(1):51-7. PubMed ID: 9496233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin E2 adds bone to a cancellous bone site with a closed growth plate and low bone turnover in ovariectomized rats.
    Ma YF; Ke HZ; Jee WS
    Bone; 1994; 15(2):137-46. PubMed ID: 8086230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risedronate plus prostaglandin E2 is superior to prostaglandin E2 alone in maintaining the added bone after withdrawal in a non-growing bone site in ovariectomized rats.
    Liang HH; Ma YF; Jee WS; Pan Z; Setterberg RB; McOsker JE; Li XJ
    Bone; 1995 Oct; 17(4 Suppl):335S-339S. PubMed ID: 8579936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.